ACM Global Central Lab's Acquisition Expands Asia-Pac Presence - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
ACM Global Central Lab's Acquisition Expands Asia-Pac Presence

Source: Applied Clinical Trials

ACM Global Central Lab announced it has acquired Phoenix Pharma Central Services (S) Pte. Ltd (Phoenix PCS), a central laboratory services provider for clinical trials in the Asia-Pacific region, by adding two clinical trial laboratory locations in Singapore and Shanghai, China. The addition of these laboratories, comes on the heels of last year’s expansion and relocation of its ACM York facilities.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here